Nuvation Bio Inc. (NUVB) Stock Price

NUVBStock

$4.45+22.59%52W

Market Cap$1.56B

P/E—

PEG Ratio—

Div yield—

Beta1.72

NUVB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-18.15%

Price vs S&P 500 (4W)-25.36%

VGM Score61.76

Book Value / Share (Quarterly)$0.73

P/TBV (Annual)10.46x

Cash Flow / Share (Quarterly)$-0.37

Price vs S&P 500 (YTD)-62.26%

Gross Margin (TTM)88.18%

Net Profit Margin (TTM)-88.19%

EPS (TTM)$-0.44

10-Day Avg Trading Volume5.82M

EPS Excl Extra (TTM)$-0.44

EPS (Annual)$-0.60

ROI (Annual)-39.81%

Gross Margin (Annual)85.22%

Cash / Share (Quarterly)$1.89

Revenue Growth QoQ (YoY)555.64%

ROA (Last FY)-34.40%

Revenue Growth TTM (YoY)1083.56%

EBITD / Share (TTM)$-0.41

ROE (5Y Avg)-45.89%

Operating Margin (TTM)-86.58%

Cash Flow / Share (Annual)$-0.52

P/B Ratio6.17x

P/B Ratio (Quarterly)7.79x

Net Income / Employee (Annual)$-686,700

EV / Revenue (TTM)10.13x

Net Interest Coverage (TTM)-24.42x

ROA (TTM)-23.49%

EPS Incl Extra (Annual)$-0.60

Current Ratio (Annual)6.95x

Quick Ratio (Quarterly)7.98x

3-Month Avg Trading Volume6.36M

52-Week Price Return22.59%

Revenue / Employee (TTM)$570,100

Tangible BV / Share (Quarterly)$0.70

P/S Ratio (Annual)24.91x

Asset Turnover (Annual)0.11x

52-Week High$9.75

EPS Excl Extra (Annual)$-0.60

CapEx CAGR (5Y)123.44%

26-Week Price Return-8.25%

Quick Ratio (Annual)6.67x

13-Week Price Return-23.28%

Total Debt / Equity (Annual)0.68x

Current Ratio (Quarterly)8.37x

Enterprise Value$1.72B

Asset Turnover (TTM)0.27x

Book Value / Share Growth (5Y)-2.24%

Revenue / Employee (Annual)$211,100

Pretax Margin (Annual)-325.31%

Cash / Share (Annual)$1.53

3-Month Return Std Dev55.18%

Net Income / Employee (TTM)$-502,800

ROE (Last FY)-66.93%

Net Interest Coverage (Annual)-25.65x

EPS Basic Excl Extra (Annual)$-0.60

Receivables Turnover (TTM)11.13x

Total Debt / Equity (Quarterly)1.63x

EPS Incl Extra (TTM)$-0.44

ROI (TTM)-26.73%

P/S Ratio (TTM)9.22x

Revenue / Share (Annual)$0.18

Tangible BV / Share (Annual)$0.85

Price vs S&P 500 (52W)7.06%

Year-to-Date Return-50.33%

5-Day Price Return-9.18%

EPS Normalized (Annual)$-0.60

ROA (5Y Avg)-35.67%

Net Profit Margin (Annual)-325.31%

Month-to-Date Return-20.54%

Cash Flow / Share (TTM)$-0.38

EBITD / Share (Annual)$-0.62

Operating Margin (Annual)-338.72%

LT Debt / Equity (Annual)0.63x

ROI (5Y Avg)-40.14%

LT Debt / Equity (Quarterly)1.55x

EPS Basic Excl Extra (TTM)$-0.44

P/TBV (Quarterly)8.12x

P/B Ratio (Annual)10.08x

Inventory Turnover (TTM)1.96x

Pretax Margin (TTM)-88.19%

Book Value / Share (Annual)$0.88

Price vs S&P 500 (13W)-25.96%

Beta1.72x

Revenue / Share (TTM)$0.49

ROE (TTM)-49.73%

52-Week Low$3.36

vGradeD

gGradeA

mGradeC

vgmGradeB

NUVB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.12	-$0.15	-25.15%(-$0.03)
Q1 2026	May 4, 2026	$0.05	$0.04	-23.60%(-$0.01)
Q4 2025	Mar 2, 2026	-$0.04	-$0.09	-91.11%(-$0.04)
Q3 2025	Nov 3, 2025	-$0.15	-$0.14	+7.00%(+$0.01)
Q2 2025	Aug 7, 2025	-$0.14	-$0.14	+1.50%(+$0.00)

NUVB Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.12

4.13

4.11

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
NUVBNuvation Bio Inc.	D	A	C	9.2x	1083.6%	88.2%	—	$4.45
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Nuvation Bio Inc.

Nuvation Bio is a biopharmaceutical company developing oncology treatments, with its lead candidate taletrectinib, an oral ROS1 inhibitor for patients with ROS1-positive non-small cell lung cancer. The clinical-stage pipeline includes additional oncology candidates at various development stages. Revenue is generated primarily through licensing agreements and research partnerships, with the majority coming from Japan.

NUVB Next Earnings Report

Report dateNov 2, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.09

Revenue estimate$34.80M

Also reporting on Nov 2, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

NUVB Insider Transactions

SellAug 19, 2026
HATTERSLEY GARY
Officer
Shares: 100,000Value: $709,240

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

OLNOlin Corp.Chemicals
MESOMesoblast Limited American Depositary SharesBiological Products
VIRVir Biotechnology, Inc. Common StockBiological Products
NTLAIntellia Therapeutics, IncIn Vitro Diagnostics
MAZEMaze Therapeutics, Inc. Common StockBiological Products
IMCRImmunocore Holdings plc American Depositary SharesBiological Products
HUNHuntsman CorporationChemicals
SCLStepan Co.Soap & Detergents

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$3.36

High$9.75